1Potential role and therapeutic implications of glutathione peroxidase 4 in the treatment of Alzheimer's diseaseYanxin Shen，Guimei Zhang，Chunxiao Wei，Panpan Zhao，Yongchun Wang，Mingxi Li，Li SunReviews613-631
2Cell polarization in ischemic stroke:molecular mechanisms and advancesYuanwei Li，Xiaoxiao Xu，Xuan Wu，Jiarui Li，Shiling Chen，Danyang Chen，Gaigai Li，Zhouping TangReviews632-645
3Toward understanding the role of genomic repeat elements in neurodegenerative diseasesZhengyu An，Aidi Jiang，Jingqi ChenReviews646-659
4From single to combinatorial therapies in spinal cord injuries for structural and functional restorationErnesto Doncel-Pérez，Gabriel Guízar-Sahagún，Israel Grijalva-OteroReviews660-670
5Crosstalk between degradation and bioenergetics:how autophagy and endolysosomal processes regulate energy productionAngelid Pabon，Jagannatham Naidu Bhupana，Ching-On WongReviews671-681
7Context-dependent role of sirtuin 2 in inflammationNoemí Sola-Sevilla，Maider Garmendia-Berges，MCarmen Mera-Delgado，Elena PuertaReviews682-694
8Liver as a new target organ in Alzheimer's disease:insight from cholesterol metabolism and its role in amyloid-beta clearanceBeibei Wu，Yuqing Liu，Hongli Li，Lemei Zhu，Lingfeng Zeng，Zhen Zhang，Weijun PengReviews695-714
9Targeting TrkB-PSD-95 coupling to mitigate neurological disordersXin Yang，Yu-Wen Alvin Huang，John MarshallReviews715-724
10Spastin and alsin protein interactome analyses begin to reveal key canonical pathways and suggest novel druggable targetsBenjamin R.Helmold，Angela Ahrens，Zachary Fitzgerald，P.Hande OzdinlerReviews725-739
11Lipid droplets in the nervous system:involvement in cell metabolic homeostasisYuchen Zhang，Yiqing Chen，Cheng Zhuang，Jingxuan Qi，Robert Chunhua Zhao，Jiao WangReviews740-750
12Role of copper chelating agents:between old applications and new perspectives in neuroscienceRosalba Leuci，Leonardo Brunetti，Vincenzo Tufarelli，Marco Cerini，Marco Paparella，Nikola Puvača，Luca PiemonteseReviews751-762
13Meningeal lymphatic vessel crosstalk with central nervous system immune cells in aging and neurodegenerative diseasesMinghuang Gao，Xinyue Wang，Shijie Su，Weicheng Feng，Yaona Lai，Kongli Huang，Dandan Cao，Qi WangReviews763-778
14Infiltration by monocytes of the central nervous system and its role in multiple sclerosis:reflections on therapeutic strategiesGuangyong Zhang，Qing Yao，Chubing Long，Pengcheng Yi，Jiali Song，Luojia Wu，Wei Wan，Xiuqin Rao，Yue Lin，Gen Wei，Jun Ying，Fuzhou HuaReviews779-793
15Mitochondrial therapeutics and mitochondrial transfer for neurodegenerative diseases and agingNeville Ng，Michelle Newbery，Nicole Miles，Lezanne OoiPerspectives794-796
16Injury/ischemia-induced stem cells:up-to-date knowledge and future perspectives for neural regenerationTakayuki NakagomiPerspectives797-798
17Insights from a proteomic atlas of human Alzheimer's disease brain tissueTomas Kavanagh，Eleanor DrummondPerspectives799-800
18Decoding complexity:the need to enhance precision and streamline spatial understanding in neuroscienceSameehan Mahajani，Armita Salahi，Brenda Gonzalez，Charlotte Nelson，Frank HsiungPerspectives801-802
19Antisense oligonucleotides provide optimism to the therapeutic landscape for tauopathiesGlenn A.Harris，Lauren R.HirschfeldPerspectives803-804
20Mitochondria-cGAS-STING axis is a potential therapeutic target for senescence-dependent inflammaging-associated neurodegenerationJosé M.IzquierdoPerspectives805-807
